Manufacturer of Controlled Substances; Notice of Registration, 20731 [E6-5965]
Download as PDF
<![CDATA[
20731
Federal Register / Vol. 71, No. 77 / Friday, April 21, 2006 / Notices
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
Manufacturer of Controlled
Substances; Notice of Registration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated November 18, 2005,
and published in the Federal Register
on November 29, 2005, (70 FR 71559),
Dade Behring Inc., Regulatory Affairs,
Quality Systems, 20400 Mariani
Avenue, Cupertino, California 95014,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in
Schedules I and II:
By Notice dated November 18, 2005,
and published in the Federal Register
on November 29, 2005, (70 FR 71559),
Dade Behring Inc., 100 GBE Drive,
MS514, Post Office Box 6101, Attention:
RA/QS, Newark, Delaware 19714–6101,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in
Schedules I and II:
By Notice dated November 18, 2005,
and published in the Federal Register
on November 29, 2005, (70 FR 71559),
ISP, Freetown Fine Chemicals, Inc., 238
South Main Street, Assonet,
Massachusetts 02702, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
Schedules I and II:
Drug
Drug
Schedule
Tetrahydrocannabionols (7370) ...
Benzoylecgonine (9180) ...............
Morphine (9300) ...........................
I
II
II
Drug
Tetrahydrocannabionols (7370) ...
Benzoylecgonine (9180) ...............
Morphine (9300) ...........................
I
II
II
The company plans to produce the
listed controlled substances in bulk to
be used in the manufacturer of reagents
and drug calibrator/controls for DEA
exempt products.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of Dade
Behring Inc., to manufacture the listed
basic classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated Dade
Behring Inc., to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: April 17, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–5962 Filed 4–20–06; 8:45 am]
rwilkins on PROD1PC63 with NOTICES
The company plans to produce the
listed controlled substances in bulk to
be used in the manufacturer of reagents
and drug calibrator/controls for DEA
exempt products.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of Dade
Behring Inc., to manufacture the listed
basic classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated Dade
Behring Inc., to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: April 17, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–5965 Filed 4–20–06; 8:45 am]
BILLING CODE 4410–09–P
BILLING CODE 4410–09–P
2,5-Dimethoxyamphetamine
(7396).
Amphetamine (1100) ....................
Phenylacetone (8501) ..................
17:21 Apr 20, 2006
Jkt 208001
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
I
II
II
The company plans to manufacturer
Phenylacetone to be used in the
manufacturer of amphetamine for
distribution to its customers. The bulk
2,5-dimethoxyamphetamine will be
used for conversion into non-controlled
substances.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of ISP,
Freetown Fine Chemicals, Inc., to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated ISP, Freetown Fine
Chemicals, Inc., to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: April 17, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–5964 Filed 4–20–06; 8:45 am]
BILLING CODE 4410–09–P
VerDate Aug<31>2005
Schedule
Schedule
E:\FR\FM\21APN1.SGM
21APN1
]]>Agencies
[Federal Register Volume 71, Number 77 (Friday, April 21, 2006)]
[Notices]
[Page 20731]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-5965]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated November 18, 2005, and published in the Federal
Register on November 29, 2005, (70 FR 71559), Dade Behring Inc., 100
GBE Drive, MS514, Post Office Box 6101, Attention: RA/QS, Newark,
Delaware 19714-6101, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic classes of controlled substances listed in
Schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Tetrahydrocannabionols (7370).............. I
Benzoylecgonine (9180)..................... II
Morphine (9300)............................ II
------------------------------------------------------------------------
The company plans to produce the listed controlled substances in
bulk to be used in the manufacturer of reagents and drug calibrator/
controls for DEA exempt products.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Dade Behring Inc., to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Dade Behring Inc., to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: April 17, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-5965 Filed 4-20-06; 8:45 am]
BILLING CODE 4410-09-P
